First human trial of new Zika vaccine

The first participant has received a dose of a new Zika virus vaccine being trialled by the University of Liverpool at the Clinical Research Facility...

Malaria vaccines need modern logistics

As we approach World Malaria Day on April 25, it is important to consider the issues and solutions in the fight against this deadly disease....

First-line defences short-lived

First-line immune defences against COVID-19 are short-lived and may explain reinfection. A new study finds that antibodies produced in the nose decline nine months after...

Potential for Mugwort allergy vaccine

Potential for Mugwort allergy vaccine: Researchers have discovered key mechanisms of allergy to pollen from the common weed mugwort, thereby also laying the foundation for...

Growing flu viruses in specialised cells

A new study published in npj Vaccines has shown that growing influenza viruses in specialised cell lines, rather than chicken eggs, improves the likelihood they will match...

Cell-based vaccine for children and adolescents

A cell-based influenza vaccine has effectively provided protection against the flu in children and adolescents, according to a new study. The research found the cell-based...

Cancer Treatment influences vaccine response

The type of cancer treatment influences vaccine response: Cancer patients are at increased risk of SARS-CoV-2 infection and severe COVID-19 courses. Coronavirus vaccination is generally...